USANA Health Sciences (USNA) Expected to Announce Quarterly Earnings on Tuesday

USANA Health Sciences (NYSE:USNA) is projected to issue its quarterly earnings data after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.49 per share and revenue of $208.82 million for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

USANA Health Sciences Stock Performance

USNA stock opened at $31.85 on Monday. The stock has a market capitalization of $607.02 million, a price-to-earnings ratio of 11.25, a PEG ratio of 0.93 and a beta of 0.87. USANA Health Sciences has a 1 year low of $30.13 and a 1 year high of $50.32. The stock’s fifty day moving average is $33.81 and its two-hundred day moving average is $36.73.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on USNA shares. DA Davidson raised their target price on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research note on Thursday, January 2nd. StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Finally, Sidoti cut USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.